SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 31, Issue 16, 2013, Pages

Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis

(6) Speight, Richard A a Nicolle, Annette b Needham, Stephanie J a Verrill, Mark W c Bryon, Jane d Panter, Simon e

a ROYAL VICTORIA INFIRMARY (United Kingdom)

b QUEEN ELIZABETH HOSPITAL (United Kingdom)

c FREEMAN HOSPITAL (United Kingdom)

d BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST (United Kingdom)

e SOUTH TYNESIDE DISTRICT HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CETIRIZINE; EOSIN; HEMATOXYLIN; IMATINIB; ISOLEUCINE; RANITIDINE; STEM CELL FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; TUMOR MARKER;

ADULT; ARTICLE; CANCER SIZE; CAPSULE ENDOSCOPY; CASE REPORT; CHRONIC DIARRHEA; CODON; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; EXON; FAINTNESS; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MALE; MAST CELL; MELENA; MISSENSE MUTATION; MUTATIONAL ANALYSIS; MYALGIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; PATIENT MONITORING; PRIORITY JOURNAL; PROTO ONCOGENE; PROTO ONCOGENE KIT; RASH; SOFT TISSUE INJURY; SPINDLE CELL CARCINOMA; STAINING; SYSTEMIC MASTOCYTOSIS; DRUG RESISTANCE; GASTROINTESTINAL TUMOR; GENETICS; MASTOCYTOSIS; MUTATION; PATHOLOGY; RADIOGRAPHY; SMALL INTESTINE;

ADULT; ANTINEOPLASTIC AGENTS; BENZAMIDES; DRUG RESISTANCE, NEOPLASM; EXONS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; MALE; MASTOCYTOSIS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84880675029 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2012.42.0133 Document Type: Article

Times cited : (17)

References (10)

1
- 66549113366
- Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Casali PG, Blay JY: Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 20, 2009 (suppl 4)
- (2009) Ann Oncol , vol.20 , Issue.SUPPL. 4
- Casali, P.G.¹ Blay, J.Y.²

2
- 34147103980
- The role of KIT in the management of patients with gastrointestinal stromal tumors
- Hornick JL, Fletcher CD: The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol 38:679-687, 2007
- (2007) Hum Pathol , vol.38 , pp. 679-687
- Hornick, J.L.¹ Fletcher, C.D.²

3
- 0036301722
- Diagnosis of gastrointestinal stromal tumors: A consensus approach
- Fletcher CD, Berman JJ, Corless C, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33:459-465, 2002
- (2002) Hum Pathol , vol.33 , pp. 459-465
- Fletcher, C.D.¹ Berman, J.J.² Corless, C.³

4
- 15644363454
- Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
- Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
- (1998) Science , vol.279 , pp. 577-580
- Hirota, S.¹ Isozaki, K.² Moriyama, Y.³

5
- 77956640525
- Implications of mutational analysis for the management of patients with gastrointestinal stromal tumours and the application of targeted therapies
- Wozniak A, Floris G, Debiec-Rychter M, et al: Implications of mutational analysis for the management of patients with gastrointestinal stromal tumours and the application of targeted therapies. Cancer Invest 28:839-848, 2010
- (2010) Cancer Invest , vol.28 , pp. 839-848
- Wozniak, A.¹ Floris, G.² Debiec-Rychter, M.³

6
- 0004259636
- (ed 5). Oxford, United Kingdom, Blackwell Publishing
- Hoffbrand AV, Catovsky D, Tuddenham EGD: Postgraduate Haematology (ed 5). Oxford, United Kingdom, Blackwell Publishing, 2006, pp 761-782
- (2006) Postgraduate Haematology , pp. 761-782
- Hoffbrand, A.V.¹ Catovsky, D.² Tuddenham, E.G.D.³

7
- 34248232533
- Systemic mastocytosis: A concise clinical and laboratory review
- Patnaik MM, Rindos M, Kouides PA, et al: Systemic mastocytosis: A concise clinical and laboratory review. Arch Pathol Lab Med 131:784-791, 2007
- (2007) Arch Pathol Lab Med , vol.131 , pp. 784-791
- Patnaik, M.M.¹ Rindos, M.² Kouides, P.A.³

8
- 0035425217
- Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa
- Beghini A, Tibiletti MG, Roversi G, et al: Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92:657-662, 2001
- (2001) Cancer , vol.92 , pp. 657-662
- Beghini, A.¹ Tibiletti, M.G.² Roversi, G.³

9
- 24144503371
- Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis
- Hartmann K, Wardelmann E, Ma Y, et al: Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 129:1042-1046, 2005
- (2005) Gastroenterology , vol.129 , pp. 1042-1046
- Hartmann, K.¹ Wardelmann, E.² Ma, Y.³

10
- 32844455834
- A novel K509I mutation of KIT identified in familial mastocytosis: In vitro and in vivo responsiveness to imatinib therapy
- Zhang LY, Smith ML, Schultheis B, et al: A novel K509I mutation of KIT identified in familial mastocytosis: In vitro and in vivo responsiveness to imatinib therapy. Leuk Res 30:373-378, 2006
- (2006) Leuk Res , vol.30 , pp. 373-378
- Zhang, L.Y.¹ Smith, M.L.² Schultheis, B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.